Form 4: NeuroPace CEO Joel Becker's Tax-Related Stock Sale

NeuroPace Inc. CEO Joel Becker reported a tax-related disposition of 5,023 common shares at $13.83 per share on March 3, 2026, following a restricted stock unit vesting.

Summary

• Joel Becker, Chief Executive Officer and Director of NeuroPace Inc. (NPCE), reported a transaction on March 3, 2026.
• 5,023 shares of NeuroPace Inc. common stock were disposed of.
• This disposition was a mandatory withholding by the Issuer to satisfy tax obligations associated with the vesting of a restricted stock unit award.
• The shares were disposed of at a deemed price of $13.83 per share.
• Following this transaction, Joel Becker directly beneficially owns 96,937 shares of NeuroPace Inc. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine tax-related transaction rather than a discretionary sale or a significant change in insider holdings.

Industry Context

StockSavvy.ai notes that tax-related dispositions of shares following restricted stock unit (RSU) vesting are common and routine for executives, not typically indicative of a change in sentiment towards the company's prospects or operational performance.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related sale, not a discretionary sale indicating a lack of confidence in the company's future.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by CEO Joel Becker to cover tax obligations upon the vesting of restricted stock units. Such transactions are common for executives and do not typically signal a change in the company's fundamentals or management's long-term outlook. Therefore, it provides no new information to warrant a change in investment recommendation.

Keywords

NeuroPace, NPCE, Joel Becker, Form 4, Insider Transaction, Stock Sale, CEO, Director, RSU, Tax Withholding